Outsourcing in Clinical Trials Southern California 2022
San Diego Marriott La Jolla, San Diego, CA
28th-29th September, 2022
Download Agenda
Outsourcing in Clinical Trials Southern California 2022
Advertisement
Arena International are delighted to announce the Outsourcing in Clinical Trials Southern California Event will be returning to California's La Jolla on September 28th & 29th 2022!
For the 9th Annual, our leading clinical show will focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed- take a look at our agenda page & list of keynote speakers.
The 2022 program boasts 2 streams jam packed with content. Day 1 will kick off with an expert Panel Discussion debating best practices for Decentralized & Hybrid Clinical Trials, led by our chair for the day, Lei Zhang (VP of Clinical Development, Frontage Laboratories).
We will also have a Keynote from Joanna Bolger (VP of Clinical Operations at Cortexyme), discussing how to nurture in-house teams and when you ACTUALLY need to outsource.
Bonnie Bain (Global Head and Executive Vice President at GlobalData) will chair our Technology & Innovation stream on Day 1, which begins with a panel asking the question; ‘Do we need to move away from digital reliance to bring the human touch back?’. Do you agree or disagree? Christopher LeMasters (EVP & COO at XinThera) will lead this panel and open up the audience to gain their input.
The Speaking Faculty includes the likes of AbbVie, Jazz Pharmaceuticals, Pfizer, Cortexyme, PTC Therapeutics, ReShape Lifesciences, Elevar Therapeutics and many more.
Don’t miss out; join us in La Jolla on September 28th & 29th. We can't wait to see you there!
A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES
This is a a networking focused event with industry leading presentations, interactive formats and the most innovative solution providers attending. Attendees will hear from industry leading speakers, learn what is round the corner in terms of future trends and get the latest knowledge on new and upcoming disruptors.
300+
ATTENDEES
65+
EXHIBITORS
30+
SPEAKERS
80%
ATTENDEES AT DIRECTOR + LEVEL

James Wabby
Executive Director, Regulatory Affairs - Device/Combination Products,AbbVie
Biography: Over 19 years of experience in increasing quality operations, quality compliance and regulatory affairs responsibilities within the GxP regulated environment pertaining to Medical Device, Digital Medicine and Combination Product areas. In addition, an adjunct assistant professor at USC – School of Pharmacy – Regulatory and Quality Sciences. Regularly provides AbbVie therapeutic franchise units regulatory counsel and strategy to all aspects within the quality management system arena and regulatory affairs regarding:
- CMC Global Dossiers and Global Device Regulatory Strategy Registrations
- EU MDR/IVDR – Person Responsible for Regulatory Compliance (PRRC)
- 21 CFR Part 3 and Part 4 - Combination Products
- CE Marking
- ISO 13485:2016/MDSAP
- Product Development – Design Controls
- Risk Management
- Human Factors Engineering
- Acquisitions/Divestitures
- Import/Export – U.S. Agent
- Production Controls
- Regulatory Inspection Management
- Materiovigilance
- Health-Care Related Laws and International Regulations
Session Details: KEYNOTE DCT & HYBRID PANEL DISCUSSION 28-09-2022, 8:30 am PANEL DISCUSSION Do we need to move away from digital reliance to bring the human touch back? Is there still a big divide? AGREE OR DISAGREE 28-09-2022, 11:00 am INTERACTIVE SESSION 28-09-2022, 12:00 pm View In Agenda

Kenneth Kleinhenz
COO,Lorem Cytori, USA
Biography: Kenneth Kleinhenzhas held numerous executive-level quality assurance and regulatory affairs position at public and private biotechnology companies to include 15 years of service as the Vice President and Chief Operating Officer at Cytori Therapeutics, a device-based, adipose-focused stem cell company. Previously, Mr. Kleinhenz was the Vice President of Quality and Regulatory at Avelas Biosciences, Director of Regulatory Affairs at MacroPoreBiosurgery, Chief Microbiologist for Becton Dickinson, and theManager of Quality Assurance and Regulatory Affairs at Pacific Pharmaceuticals. Mr. Kleinhenz is a veteran of the United States Navy where he served as a Clinical Microbiologist for 6 years at the NavalHospital, San Diego. Mr. Kleinhenzreceived his BS in Microbiology at the University of California, San Diego (UCSD) and his MBA in Technology Management at the University of Phoenix.
Session Details: PANEL DISCUSSION Do we need to move away from digital reliance to bring the human touch back? Is there still a big divide? AGREE OR DISAGREE 28-09-2022, 11:00 am KEYNOTE New patient recruitment challenges in a post-Covid world 29-09-2022, 8:30 am View In Agenda

Bonnie Bain, PhD
Global Head and Executive Vice President of Healthcare Operations and Strategy,GlobalData Healthcare
Biography: Bonnie Bain, PhD, is the Global Head and EVP of Healthcare Operations and Strategy. Bonnie has over 20 years’ experience in the healthcare sector and a proven track record of developing innovative solutions on both the client and agency sides of the business. Bonnie was GlobalData Healthcare’s first Western analyst, and under her leadership, the company launched a number of premium syndicated reports, analytical tools, and databases in the pharmaceuticals and medical devices space. Prior to GlobalData, Bonnie was Vice President and Global Research & Analysis Director for Informa’s Pharma Division, which includes Datamonitor Healthcare, Scrip Group, and Business Insight. Bonnie also worked for several years at Decision Resources as an Analyst and Project Manager. On the client side of the industry, Bonnie worked for several years as a Senior Manager in Marketing Strategy and Analytics at Boston Scientific, where her work contributed to the successful commercialization of the first ever Access and Visualization Platform at the company. Bonnie has a PhD in Biochemistry and Molecular Biology from Purdue University and completed a Post-Doctoral Fellowship in Molecular Pharmacology at the University Of Miami School Of Medicine. She also has a graduate certificate in Applied Management Principles from Purdue University Krannert School of Management.
Session Details: Chair’s Opening Remarks 29-09-2022, 8:25 am GLOBALDATA SPOTLIGHT Embracing Disruption in Pharma - Is COVID-19 a Catalyst for Lasting Change? 29-09-2022, 2:00 pm View In Agenda

Dov Gal
VP Regulatory, Clinical and Quality and Compliance Officer,ReShape Lifesciences
Biography: Dr. Gal has over 30 years of medical device experience as a practicing veterinarian, academician at Tufts University School of Medicine and subsequently in industry. Dov held R&D, clinical marketing and clinical affairs positions with increasing responsibilities in private start-up, and medium to large public medical device companies. Most recently, Dov led the clinical organization for the Heart Valve Therapy business at Edwards Lifesciences, overseeing clinical trials of Class III implantable devices. Prior to Edwards Lifesciences, he led the clinical organization at Broncus Technologies, a start-up with an investigational, minimally invasive device-drug combination product for the treatment of patients with severe COPD. The system was evaluated in an international clinical trial under an IDE. Prior to Broncus, Dov was a director of clinical research at Medtronic Vascular responsible for the AAA stent graft product line
Session Details: PANEL DISCUSSION ClinOps team focus: Managing relationships and hiring in the new world 28-09-2022, 11:00 am View In Agenda

Christine Von Raesfeld
Independent Patient Advocate,
Biography: Few people with a cause walk the talk as boldly and graciously as Christine Von Raesfeld, founder and CEO of People with Empathy. Christine is a pillar of patient advocacy and allyship in the rare and chronic disease community. Through the lens of her lived experiences in healthcare, she has become a champion for patient voices, diversity and inclusion in clinical research, and equitable patient-sponsor partnerships. Christine has brought her unique perspective and honed expertise to countless roles as a featured speaker for numerous conferences dedicated to the rare disease community and disease awareness initiatives. Wherever possible, Christine generates momentum toward progress along her patient advocacy interests and stimulates dialog on a range of topics relevant to patients, clinicians, and industry. As a patient advisor, Christine has assisted several initiatives including the Stanford "Humanwide" Precision Medicine Program, All of Us Research, and the 23andMe Lupus initiative. For her many contributions to her field, she has been named one of the top 100 Women of Influence by Silicon Valley Business Journal, a member of the 2021 HIMSS Future 50, and one of Medika Life's medikal life 50 most influential voices in healthcare 2022 among other distinctions. With her guidance and support, we will continue to optimize the patient journey for people worldwide.
Session Details: Data: the new (s)oil in a digitally driven economy 28-09-2022, 3:00 pm View In Agenda

Christopher Lemasters
EVP & Chief Operating Officer,Amplyx Pharmaceuticals, now a subsidiary of Pfizer
Biography: Chris LeMasters is the EVP & Chief Operating Officer of Amplyx Pharmaceuticals, now a wholly owned subsidiary of Pfizer, Inc. Amplyx has focused on the development of novel first-in-class therapies for infectious disease affecting immune compromised patients. He led the strategic efforts that resulted in Amplyx’s acquisition by Pfizer in April 2021. Mr. LeMasters was previously Executive Vice President and Chief Business Officer of Mirati Therapeutics, a clinical-stage oncology company, where he was responsible for corporate development, strategy and investor relations. During his three years in this role, he oversaw the successful expansion of the company and its market capitalization from $100 million in 2016 to nearly $5 billion in December 2019.
Session Details: PANEL DISCUSSION Do we need to move away from digital reliance to bring the human touch back? Is there still a big divide? AGREE OR DISAGREE 28-09-2022, 11:00 am AUDIENCE Q+A A playbook for how to handle an undesirable CRO-sponsor partnership & how to turn it around 28-09-2022, 4:30 pm AUDIENCE Q+A: A playbook for how to handle an undesirable CRO-sponsor partnership & how to turn it around 28-09-2022, 4:30 pm View In Agenda

Jennifer Lee
Senior Vice President of Clinical Operation, Biostats, and Data Management ,Elevar Therapeutics
Biography: Jennifer Lee is Senior Vice President of Clinical Operation, Biostats, and Data Management at Elevar Therapeutics. Jennifer brings over 25 years of industry expertise in clinical strategies, asset evaluation, and advancing novel and innovative clinical programs spanning phases I-IV across therapeutic areas, including oncology, infectious disease, inflammation, urology, CNS, cardiovascular, rare disease, and stem and cell therapies. She is an invited speaker at international conferences and has successfully submitted market applications leading to seven NDA approvals. Previously, Jennifer worked at G.D. Searle, Pharmacia, Pfizer, Astellas Gilead Sciences, and other mid- and micro-cap companies. Jennifer holds a BS in Biochemistry from the University of Illinois and an MS in Clinical Research and Regulatory Administrations from Northwestern University. She is an active mentor, Women in Bio supporter, and board member.
Session Details: PANEL DISCUSSION ClinOps team focus: Managing relationships and hiring in the new world 28-09-2022, 11:00 am FIRESIDE CHAT Establishing strong CRO/sponsor/site relationships and building trust 28-09-2022, 12:00 pm View In Agenda

Ken Wilson
Outsourcing Lead,Pfizer
Biography: Ken has been in the industry for over 30 years, with just over 20 in the CRO world, at Quintiles, Statprobe, and Clinimetrics/Omnicare. Ken joined Pfizer in 2010 in an outsourcing role, and has been leading outsourcing efforts for multiple development programs. Experience prior to Pfizer includes hands-on and line management roles in Statistical Programming, Biostatistics, Data Management, and Project Management, as well as overall responsibility for a local CRO office in San Diego that employed more than 70 local employees.
Session Details: View In Agenda

Bai Xu
CEO,Nanomed
Biography: Nanomed, with the headquarter at Cupertino, CA, applies innovative microfabrication technology to make a delivery tool for skincare actives. This is a new way of overcoming skin barrier and delivering actives without needle injection. The product successfully went through two clinical trials and got into the finals of Asian Innovation Award together with IBM Healthsolution Lab's product sponsored by the Wall Street Journal and won Silver Prize in 2010. Nanomed's antiblemish product was successfully launched at AAD, the largest dermatology annual meeting in US. Together with Sephora's product, Nanomed's delivery product got into the top three for the International Package Design Award (tool category) at 2012 HBA Global in New York City.
Session Details: A Fireside Chat on…Regenerative Medicine as a future trend 28-09-2022, 3:00 pm View In Agenda

Lei Zhang
Former VP, Global Project Management & Scientific Affairs,Frontage Laboratories, Inc.
Biography: Dr. Lei Zhang has over 25 years of experience spanning across the biotech/biopharma, medical device, and diagnostic industries. Her unique drug development lifecycle expertise includes clinical development/operations, scientific innovation and regulatory interactions with the FDA (CDER, CBER, CDRH). Lei serves as VP of Global Scientific & Regulatory Affairs at Frontage Labs. She obtained her PhD in Germany and performed Postdoc Research at MIT.
Session Details: Chair’s Opening Remarks 28-09-2022, 8:20 am KEYNOTE DCT & HYBRID PANEL DISCUSSION 28-09-2022, 8:30 am FIRESIDE CHAT Establishing strong CRO/sponsor/site relationships and building trust 28-09-2022, 12:00 pm View In Agenda

Steven Chen
Chief Medical Officer ,Avelas Biosciences
Biography: Steven Chen, MD, MBA is the Chief Medical Officer of Avelas Biosciences in La Jolla, CA, a company with a drug/device combination focused on intraoperative margin detection. He is also a surgical oncologist in San Diego, CA. Dr. Chen received his medical degree and completed general surgery and critical care residencies at the University of Michigan, followed by a surgical oncology fellowship at the John Wayne Cancer Institute. Subsequently, he was the Chief of Breast Surgery at UC Davis Medical Center, and an Associate Professor of Surgery at City of Hope National Medical Center. He serves as the Director of Surgical Oncology at OasisMD. Dr. Chen is a past President of the American Society of Breast Surgeons and serves on committees for a number of professional societies including the American Medical Association and the American College of Surgeons
Session Details: PANEL REUNION DEBATE POST COVID: How long will we feel ripples of the pandemic? 29-09-2022, 11:00 am View In Agenda

Stefan Lukianov
CEO ,Salve Therapeutics
Biography: Stefan N. Lukianov, AM MS is the first-time JHU grad student founder of Salve Therapeutics, Inc. of Los Angeles, CA. He has undergraduate degrees from the University of Maine and masters from the University of Pittsburgh and Harvard University in the biomedical sciences. He has worked in reputable labs at Boston Children’s Hospital, Brigham and Women’s Hospital, McLean Hospital and the UPMC Hillman Cancer Center. He also has extensive experience in science journalism and education that contribute to his company leadership and vision.
Session Details: Speaker Hosted Roundtables 29-09-2022, 3:00 pm View In Agenda

Joseph Shan
Executive Director, Clinical Development Operations,MEI Pharma
Biography: Collaborative and outcome-based biopharmaceutical servant-leader providing 20+ years of clinical operations experience. Passionately advancing the mission of improving patients’ lives through timely and efficient execution of clinical trials. Adept at building and managing cross-functional teams comprising internal and/or external partners and CROs to meet the dynamic business needs of virtual start-ups to leading life science companies.
Session Details: View In Agenda

Wendy Wu
Sr Director, Clinical Development ,Jazz Pharmaceuticals
Biography: Certificated professional for clinical research and regulatory affairs, with over 15 years of experience in designing, conducting, and reporting clinical & medical trials for investigational therapeutic products and companion diagnostic/prognostic products. Broad clinical and scientific knowledge and industrial experience across multiple therapeutic areas including diabetes, GI, oncology, and rheumatology. Experience in working with both small molecules and biologic agents. Track record in executing and overseeing clinical studies from early phase to large-scale global registrational trials (phase I to IV), including clinical reporting and regulatory submissions that have led to successful market approvals in multiple products. Accomplished in mid-sized to large pharmaceutical corporations, with ability to balance corporate obligations with day-to-day responsibilities of developing effective and safe new therapies and clinical tools.
Session Details: EDC: Discovering data capture in the age of Decentralized and Hybrid trials 28-09-2022, 2:00 pm View In Agenda

Joanna Bolger
VP of Clinical Operations ,Cortexyme
Biography: Clinical Operations Leader with over 18 years of drug development and clinical project management experience. I am very passionate about drug development process and bringing new therapies to patients in need. My expertise benefits small and large biotech and pharmaceutical companies with all stages of drug and medical device development programs. I have worked in the following therapeutic areas: Alzheimer’s disease, oncology (hematologic malignancy T- cell therapy, and solid tumors), cardiology (stem cell therapy), infectious diseases, endocrinology and rare diseases.
Session Details: View In Agenda

AJ Bergmann
Chief Financial Officer,Capricor Therapeutics
Biography: AJ Bergmann is currently the Chief Financial Officer of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Mr. Bergmann joined Capricor in 2011 and he also serves as the Company’s corporate treasurer. During his time at Capricor, Mr. Bergmann directly coordinated the Company’s reverse merger and subsequent uplisting to the NASDAQ and financings yielding over $100.0 million, to date. He has experience in developing corporate and financial strategy alternatives and executing strategic plans. Mr. Bergmann manages the Company’s finance, accounting, business development, and human resource functions. Prior to joining Capricor, Mr. Bergmann had experience in accounting, finance, and operations management of companies ranging in size from start-ups to mid-size companies. Most recently he was with the business management firm, Gettleson, Witzer, and O’Connor, in Beverly Hills, California, where he focused on accounting and finance for several production studios generating motion picture releases and worldwide revenue that exceeded $1 billion. The firm’s clients included foundations, trusts, and independent actors, writers, producers and directors across the entertainment industry. While at the firm, he focused on budgeting, tax forecasting, and asset management. Earlier in his career, Mr. Bergmann served in financial positions in various industries. Mr. Bergmann graduated from Providence College with a Bachelor of Science degree in Management and a minor in Finance. He has an M.B.A. from the University of Southern California’s Marshall School of Business.
Session Details: Facing up to increased trial costs: Top tips for staying in budget 29-09-2022, 12:00 pm View In Agenda

Majid Ghoddusi
Senior Director, Clinical Biomarkers,Poseida Therapeutics
Biography: Dr Ghoddusi has over 15 years of experience in some of the most challenging areas of oncology with focus on drug discovery and clinical development. Dr Ghoddusi has broad and overarching insights into unmet therapeutic areas with expertise in translational sciences and clinical biomarker development which allows him to provide unique perspective on how to propel therapeutic projects from discovery to approval. Trained as a translational pathologist he has held numerous positions at large pharmaceutical and small biotech companies including Novartis, Celgene, and Juno Therapeutics. His current focus is Immuno-oncology, Gene and Cellular Therapy.
Session Details: Delving into the laboratory aspects of clinical trials in the new age 28-09-2022, 2:00 pm View In Agenda

Melody Anderson
Sr Director, Clinical Operations,Avelas Biosciences
Biography: Melody began her clinical career over 35 years ago at Abbott HPD in Illinois; she moved to California to work for Syntex (now Roche). She has worked for several small biotech companies with experience in medical devices, pharmaceuticals, biologicals, drug/device combinations, and drug delivery systems. In 2001 she relocated to AUSTRALIA to establish a subsidiary of Clinimetrics; she subsequently worked for St. Jude Medical--Australia. Upon returning to San Diego in mid-2009 she was a clinical consultant for a few years before returning to industry in 2015. She is currently employed by Avelas Biosciences, a COI Pharmaceuticals company.
Session Details: PANEL REUNION DEBATE POST COVID: How long will we feel ripples of the pandemic? 29-09-2022, 11:00 am View In Agenda

Terry Arnold
Senior Director of Medical Affairs,DermTech
Biography:
Session Details: Managing clinical studies at medical device startups 29-09-2022, 1:30 pm View In Agenda

Peter B. Heifetz
President and CEO,OrPro Therapeutics
Biography:
Session Details: Speaker Hosted Roundtables 29-09-2022, 3:00 pm View In Agenda

Mary Syto
Director, Clinical Scientists, Early Clinical Development,Bristol Myers Squibb
Biography: Experienced Clinical Research Scientist with 20+ years of experience in pharmaceutical drug discovery and development in CRO and industry settings. Most recent clinical development experience in multiple sclerosis space leading to the successful marketing authorization of Zeposia (ozanimod) in the US and Europe. Therapeutic areas: Dermatology, Gastroenterology, Immunology/Inflammation, Neurology, and Oncology (Hematology and Solid Tumors).
Session Details: PANEL DISCUSSION ClinOps team focus: Managing relationships and hiring in the new world 28-09-2022, 11:00 am View In Agenda

Sverre Bengtsson
Co-Founder,Viedoc Technologies
Biography: Sverre Bengtsson started in the clinical trials industry over 30 years ago. He started as a statistician/statistical programmer, later into data management and since over 20 years into business development. He has been working in both CRO’s as well as in clinical trials technology companies, including the global first ePRO company. Sverre is very interested in making clinical trials efficient, in both study design but also in the processes and technologies used. Sverre co-founded Viedoc Technologies 19 years ago and is responsible for some of the major accounts but also the vision around the company. He’s on the board of both some industry organisations and in clinical technology companies.
Session Details: Decentralized clinical trials and hybrid trials: what you need to understand to run these successfully 28-09-2022, 11:30 am View In Agenda

Jena Daniels
VP Patient Success,Medable
Biography: Jena is an experienced research manager with 10 years of experience in enabling digital solutions within academic and industry sponsored clinical trials. As a 2021 PharmaVoice100 recipient and Best Decentralized Clinical Trial Businesswoman of 2022, Jena is most known for establishing Medable's Patient Success department and Patient Caregiver Network. These teams engage and empower expert patient and caregiver advocates to assist product development, refine study workflows, and tailor the overall trial experience. This results in meaningful, actionable, and patient-focused solutions. She is incredibly passionate about enabling effective therapies to get to patients faster by disrupting legacy standards with scalable and personalized digital solutions. Prior to Medable, she worked as a Clinical Research Manager at Harvard Medical School and Stanford University School of Medicine. She has co-authored over 30 peer-reviewed publications focusing on how to leverage machine-learning, artificial intelligence, and remote patient monitoring to triage, diagnose, and provide early intervention for children with autism spectrum disorder
Session Details: How to combine tech and patient perspectives to decrease costs and increase enrollment 28-09-2022, 12:30 pm View In Agenda

Chris Hickey
Executive Vice President — Business Development, Nucleus Network
Biography: Chris has dedicated his 16-year career to the services side of the Phase 1 clinical drug development industry, including both operational and business development roles. Starting as a Clinical Research Coordinator and Project Manager at Charles River Clinical Services (formerly Northwest Kinetics) where he was directly responsible for the delivery of many Phase 1 clinical studies, was instrumental in his future success in a business development role. After joining SNBL CPC in 2010, Chris had an active field-based BD role in the US and was responsible for delivering a large majority of the business into the Phase 1 unit during his tenure. Assuming responsibility for the management of the BD function as Vice President in 2015, he was a key member of the team that delivered on corporate growth objectives by building, training and managing a high performing field-based sales team. This effort helped lead to the acquisition of SNBL CPC by Pharmaron Inc. in 2017. After the acquisition he remained a key resource for the Pharmaron executive management team during the transition period, assisting in the integration of the US Clinical Development team within the global Pharmaron organization. He continued to lead the global business development effort for the US based Phase 1 unit for four years. Chris’ deep knowledge of the global early phase drug development industry will strengthen the tradition of success for our company, customers and partners.
Session Details: Achieving Phase 1 value inflection rapidly and robustly in Australia and the USA 28-09-2022, 2:30 pm View In Agenda

Abie Ekangaki
Vice President, Statistical Consulting, Premier Research ,
Biography: Abie Ekangaki is responsible for bringing expertise in biostatistics to shape clinical trial design strategies and methodologies for regulatory submissions and otherwise and provides broad biostatistical consulting for both internal and external clients. He advises on efficient trial designs for clinical trial programs and applies his statistical expertise, drug development, and operational experience across different therapeutic areas. With more than 25 years of experience as a biostatistician, Dr. Ekangaki has worked as a research scientist with the World Health Organization in Switzerland, as a statistics lecturer at Macquarie University in Australia, and has over 19 years in the pharmaceutical industry in both large pharma and CROs, where he has held several lead technical and senior leadership positions.
Session Details: Phase 2 Dose-Finding Trials: Are Adaptive Designs Preferred? 29-09-2022, 10:00 am View In Agenda

Bonne Adams
Executive Vice President Clinical Operations,TRACON Pharmaceuticals
Biography: Ms. Adams joined us as our Vice President of Clinical Operations in August 2006, was promoted to Senior Vice President of Clinical Operations in July 2014, and was promoted to Executive Vice President of Clinical Operations in January 2019. Prior to joining us, Ms. Adams was a Manager of Clinical Operations at Pfizer, Inc., a pharmaceutical corporation, from 2004 to 2006 and at Biogen Idec, Inc., a biotechnology company, from 2002 to 2004. Ms. Adams managed clinical trials at Pfizer that contributed to the 2006 approval of Sutent® in renal cell carcinoma and gastrointestinal stromal tumors, and she managed clinical trials at Biogen Idec that fulfilled post-approval commitments for Zevalin® and Rituxan®. Ms. Adams has managed both early and late-stage oncology studies of small molecules as well as biologics in the areas of lymphoma, lung, colorectal, ovarian, kidney, sarcoma and breast cancers. From 2000 to 2002, she managed non-oncology programs at Quintiles Inc., a service provider for biopharmaceutical and health sciences companies, including studies in the areas of allergy and pulmonary disease. Ms. Adams received a B.A. in Kinesiology and Biology from the University of Colorado and an M.B.A. in Technology Management from The University of Phoenix.
Session Details: IN-HOUSE VS OUTSOURCE Developing and nurturing in-house teams in companies with limited resources to streamline ClinOps; when do you ACTUALLY need to outsource? 29-09-2022, 9:30 am View In Agenda

Alexis Garelli
Technical Solutions Director,Calyx
Biography: Alexis Garelli has over 15 years of diverse healthcare information and pharmaceutical software technology experience. She has worked with Calyx for over 7 years as a key strategic leader and director in IRT solutions and services.
Session Details: How to leverage IRT to match the increasing need for flexibility in the clinical supply chain 29-09-2022, 11:30 am View In Agenda

Laney Preheim
Vice President, Connected Health Services & Operations,ICON
Biography: Laney Preheim has over 20 years in the high tech industry, with the majority of her career focused on the unique intersection between healthcare and technology. She leads the global Concierge Support & Coordinating Center (CSCC) which includes offerings such as direct to patient services, site support, device logistics and patient safety surveillance and reporting. Laney’s team drives services that deeply consider and improve the patient journey and site staff study experiences, across the clinical trial process. She joined ICON in 2021 through the acquisition of PRA Health Sciences. Prior to this Laney was a key member in the formation of the executive leadership team at Care Innovations, a unique remote monitoring start-up. Ms. Preheim previously held a variety of positions at Intel Corporation in the Digital Health and Information Technology organizations, with focus on procurement, ecosystem enablement, product management and strategic planning where she has been at the forefront of managing organizational operations for the development of innovative strategies . She earned a Bachelor of Business Administration degree from the University of California, Davis.
Session Details: Decentralized clinical research is more than just technology: how concierge services facilitate successful implementations 28-09-2022, 11:30 am View In Agenda

Kelly Franchetti
Senior Vice President and Global Head, Patient Insights and Strategy,YPrime
Biography: Kelly Franchetti is a Sr. Vice President and Global Head of Patient Insights and Strategy at YPrime. A highly experienced registered nurse who continues to spend time with patients directly, her diverse background comprises patient advocacy and clinical research. Kelly has over 25 years of experience in obtaining and discerning the patient and caregiver experience as well as developing strong relationships with advocacy groups on a global scale. She has extensive experience in multiple therapeutic areas such as oncology, cardiovascular, endocrinology, orthopedics, infectious disease, neurology, pediatrics, and critical care. This depth and breadth of experience translate into a keen understanding of how patients think regarding their treatment giving her a singular perspective on the best way to approach patients with their treatment options, and an understanding that proves invaluable to her pharmaceutical and clinical research stakeholders.
Session Details: Remember the patient? Humanizing Decentralized Clinical Trials during their study journey 29-09-2022, 9:00 am View In Agenda

Jorge Franceschi
Director, Business Development,TrialCard
Biography: Since 2002 Jorge has been involved in pharmaceutical, biotech, and biologics research in a variety of roles including clinical, operations, finance, market Intelligence and business development at the site level, SMO, CRO, and now for clinical supply solutions and access at TrialCard. Past employment includes Sarkis Clinical Trials, Radiant Research, Covance, Interventional Concepts, MedPrimo Research as an independent consultant, FutureLife LLC advisory board member, and the University of Florida/VAMC Department of Neurology. Cumulatively he has been involved in over 350 clinical trials including Phase I-IV, PK/PD, vaccine, 510k submission, vaccine research, and has conducted both pediatric and adult trials. Mr. Franceschi completed his undergraduate work at the University of Florida in Food Science & Human Nutrition and completed his Masters of Science in Health with emphasis in nutrition at the University of North Florida in Jacksonville. A majority of his clinical trial work has been within the CNS realm supporting major depressive disorder, anxiety, bipolar, ADHD, and PTSD research but most recently he is learning about and supporting clinical teams needing oncolytic co-therapy medications.
Session Details: Innovative solutions for today’s clinical trial needs 28-09-2022, 4:00 pm View In Agenda

Nisha Trivedi
Patient Advocate,
Biography: For the last few years, Nisha has been a patient advocate for the rare disease community, raising public awareness of the genetic skin disorder Epidermolysis Bullosa. Through the EveryLife Foundation’s Rare Disease Week on Capitol Hill and Rare Across America events, along with other organizations' advocacy events, she has shared her story with members of Congress to encourage them to support policies that benefit rare disease patients. She currently represents EB Research Partnership on EveryLife Foundation's Community Congress. Previously, she spent six years on the board of directors of The Shanti Project, a San Francisco–based nonprofit that enhances the health, quality of life, and well-being of people with serious illnesses. Nisha lives in South San Francisco, CA and works at mbaMission, a leading MBA admissions consulting firm, guiding applicants to top business schools in the U.S. and abroad in building their personal brands by identifying and showcasing the strongest aspects of their candidacy in their applications. She is also a certified business etiquette trainer, and coaches organizations on positive professional behaviors. Her BA in Communication from the University of Pennsylvania and deep interest in understanding the consumer inspired her to initially pursue a career in marketing research, which led her to positions at Time Inc., Rosetta, and KPMG LLP in New York City. After getting her MBA from the University of Michigan Ross School of Business, Nisha worked in brand management in San Francisco at Big Heart Pet Brands (now part of The J.M. Smucker Company).
Session Details: How to combine tech and patient perspectives to decrease costs and increase enrollment 28-09-2022, 12:30 pm View In Agenda

Dimitri Talantov
Head of Experimental Medicine, Infectious Diseases,The Janssen Pharmaceutical Companies of Johnson & Johnson
Biography:
Session Details: KEYNOTE DCT & HYBRID PANEL DISCUSSION 28-09-2022, 8:30 am View In Agenda













Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.







With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.






Deep 6 AI is the leader in precision research software, connecting all research stakeholders in an AI-powered, real-time, data-driven, collaborative ecosystem. Our Precision Matching software mines millions of patient records, including “unstructured” physician notes, to pin-point eligible study patients in real-time. Deep 6 eliminates months of manual data validation, to de-risk and accelerate clinical trials, because clinical trials should be a gatekeeper (accelerator), not a bottleneck to innovation.













Philips BioTel Research is an industry leader in medical imaging and cardiovascular safety testing for clinical trials.
Philips BioTel Research offers global operational support for cardiovascular monitoring in all therapeutic areas, and advances imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians – who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on or scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.













1nHealth Delivers Patient-Centric Online Recruitment.
We believe patient recruitment is about starting conversations. The most important elements: Who you talk to and What you say.
The future is almost certainly a personalized one, and that’s how we approach recruitment today. We exist to reach the right people, and present the study’s messaging that meets them where they are.
We deploy our patient-centric, inclusive targeting using engaging study assets that deliver high volumes of pre-qualified study participants, and it works…for Sponsors, and for Patients.
1nHealth. We Fill Studies.



The medical device and diagnostic industry is currently valued at over $350 billion. Technological advances in medical device and diagnostics design are driven by an increasingly demanding market and legislative requirements. A growing patient population and a worldwide governmental drive towards preventive therapies are also fuelling the development of innovative devices.
Medical Device Developments is published in response to the increasing information needs of the major global medical device manufacturers/OEMs. The publication, which is published biannually, will incorporate authoritative reviews of current trends and emerging technologies, and provide the industry's decision-makers with clear, concise and unbiased technical articles and case histories on cutting edge developments, products and applications, drawing on the expertise of leading engineers and designers from around the globe.
L: www.linkedin.com/groups/2098440
T: Medical Device (@MedDeviceDevpt) / Twitter

Today’s healthcare providers are faced with the almost impossible task of increasing the standard of care afforded to each patient, while reducing the operational costs associated with providing this improved level of care. The care delivered throughout a healthcare facility is crucial to patient outcomes; from the emergency department through to outpatient operations, encompassing wound care, critical care and clinical care at the bedside..
e-Care, which spans the entire spectrum of patient care, is also a rapidly growing area, and one that healthcare professionals are embracing not only to improve the standard of care in areas including medication administration and patient education, but also to reduce spending. Throughout a patient’s stay in a medical facility, clinicians are faced with inevitable challenges including staff management and education, infection control and equipment failure.
Practical Patient Care is published specifically to provide medical practitioners and senior managers with the information they need in order to deliver successful care management strategies that will allow them to achieve their objective of improving patient care at a reduced cost..
L: www.linkedin.com/company/practical-patient-care
T: twitter.com/P_PatientCare


Pharmaceutical Technology
SPONSORSHIP OPPORTUNITIES
Nick McCudden
T: +61 280 978 126
E: NicholasMcCudden@arena-international.com
SPEAKING OPPORTUNITIES
Chloe Roberts
T: +44 (0) 207 936 6822
E: chloe.roberts@arena-international.com